Intragastric Balloon Market Growth, Size, Share, Trends, Revenue, Challenges and Future Outlook
Intragastric Balloon Market Size- By Type, By Administration, By Filling Material, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Jan-2018 | Report ID: HLCA1804 | Pages: 1 - 106 | Formats*: |
| Category : Healthcare | |||
Intragastric Balloon Market Introduction and Overview
According to SPER Market Research, the Global Intragastric Balloon Market is estimated to reach USD 0.38 billion by 2033 with a CAGR of 17.31%.
The report includes an in-depth analysis of the Global Intragastric Balloon Market, including market size and trends, product mix, distribution channels, and supplier analysis. The intragastric balloon is a temporary medical device used for weight reduction. It involves inserting an inflatable silicone balloon filled with saline into the stomach. This method is promoted as a solution for weight loss when traditional methods like diet and exercise have not been successful, and surgery is not recommended. The balloon helps people lose weight by limiting the amount of food they can eat and encouraging a fullness feeling by taking up space in the stomach. This procedure is particularly beneficial for individuals who are overweight and at risk of serious weight-related health conditions such as heart disease, stroke, high blood pressure, and type II diabetes. Candidates for the intragastric balloon typically have a BMI ranging from 30 to 40.
- In July 2020, Allurion Technologies increased its market share in Asia by launching the Elipse Programme in Singapore, Malaysia, and Hong Kong. This project aims to give people in the area access to non-invasive weight loss treatments.
- Apollo Endosurgery, Inc. received approval from the U.S. Food and Drug Administration (FDA) for the ORBERA intragastric balloon, a medical device designed to aid adults with obesity. This approval enabled the company to broaden its product offerings and cater to a wider range of customers, contributing to the expansion of its product portfolio.
-01037137072023.jpg)
Market Opportunities and Challenges
There are numerous opportunities and challenges faced by the global intragastric balloon market. The intragastric balloon market is experiencing growth due to a rise in research and development endeavors, which creates favorable opportunities for market expansion. Additionally, the emergence of new markets and the introduction of new products contribute to the positive prospects of the intragastric balloon market, fostering growth throughout the forecast period. Additionally, opportunities come from factors such as rising obesity rates, increased acceptability of weight control, increased demand for non-surgical options, and technological improvements.
In contrast, challenges in the intragastric balloon market encompass factors such as limited long-term effectiveness, potential side effects and complications, issues related to cost and reimbursement, and competition from surgical alternatives. Achieving sustained growth and capitalizing on the opportunities in the industry will require businesses to carefully navigate these variables. Finding the right balance between addressing challenges and leveraging opportunities will be crucial for long-term success in the intragastric balloon market.
-01037077072023.jpg)
Market Competitive Landscape
Established market players in the intragastric balloon industry employ key strategies such as mergers and acquisitions, divestments, and new product development and launches. On the other hand, emerging players focus on securing funding for their product development and launch. These strategic approaches are used by companies to strengthen their market position, expand their product portfolios, and capitalize on emerging opportunities in the intragastric balloon market. Key players in the market include Allurion Technologies, Inc., Apollo Endosurgery, Inc., Endalis, Helioscopie, Lexel Medical, MEDSIL, Obalon Therapeutics, Inc., ReShape Medical, Inc., Spatz3, others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type, By Administration, By Filling Material, By End User |
| Regions covered | Asia-Pacific, Europe, Middle East and Africa, North America, Latin America, Others |
| Companies Covered | Allurion Technologies, Inc., Apollo Endosurgery, Inc., Endalis, Helioscopie, Lexel Medical, MEDSIL, Obalon Therapeutics, Inc., ReShape Medical, Inc., Spatz3, others |
COVID-19 Impact on Global Intragastric Balloon Market
The COVID-19 epidemic has had a substantial influence on the global intragastric balloon business. Healthcare systems and elective surgeries among other non-essential medical treatments were affected by the pandemic. As a result, fewer intragastric balloon procedures were carried out throughout the epidemic. The production and distribution of intragastric balloons were also impacted by supply chain disruptions and logistical issues. The market is anticipated to revive when things start to get better though, led by a growing emphasis on weight management and the return of elective surgeries. The long-term effect will rely on variables including vaccination rates, containment measure efficacy, and global healthcare system recovery.
Key Target Audience
- Non-Surgical Weight Loss Seekers
- Overweight or Obese Individuals
- Preoperative Weight Loss Candidates
- Weight Loss Maintenance
- Others
Our in-depth analysis of the Intragastric Balloon Market includes the following segments:
| By Type: |
|
| By Administration: |
|
| By Filling Material: |
|
| By End User: |
|
Key Topics Covered in the Report
- Global Intragastric Balloon Market Size (FY’2023-FY’2033)
- Overview of Global Intragastric Balloon Market
- Segmentation of Global Intragastric Balloon Market By Type (Dual Intragastric Balloons, Single Intragastric Balloons, Triple Intragastric Balloons)
- Segmentation of Global Intragastric Balloon Market By Administration (Endoscopy, Pill Form)
- Segmentation of Global Intragastric Balloon Market By Filling Material (Gas Filled, Saline Filled)
- Segmentation of Global Intragastric Balloon Market By End User (Ambulatory surgical centers, Clinics, Hospitals)
- Statistical Snap of Global Intragastric Balloon Market
- Expansion Analysis of Global Intragastric Balloon Market
- Problems and Obstacles in Global Intragastric Balloon Market
- Competitive Landscape in the Global Intragastric Balloon Market
- Impact of COVID-19 and Demonetization on Global Intragastric Balloon Market
- Details on Current Investment in Global Intragastric Balloon Market
- Competitive Analysis of Global Intragastric Balloon Market
- Prominent Market Players in the Global Intragastric Balloon Market
- SWOT Analysis of Global Intragastric Balloon Market
- Global Intragastric Balloon Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Intragastric Balloon Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Intragastric Balloon Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Intragastric Balloon Market
7. Global Intragastric Balloon Market, By Type (USD Million)
7.1. Global Intragastric Balloon Market Value Share and Forecast, By Type, 2023-20337.2. Dual Intragastric Balloons7.3. Single Intragastric Balloons7.4. Triple Intragastric Balloons
8. Global Intragastric Balloon Market, By Administration (USD Million)
8.1. Global Intragastric Balloon Market Value Share and Forecast, By Administration, 2023-20338.2. Endoscopy8.3. Pill Form
9. Global Intragastric Balloon Market, By Filling Material (USD Million)
9.1. Global Intragastric Balloon Market Value Share and Forecast, By Filling Material, 2023-20339.2. Gas Filled9.3. Saline Filled
10. Global Intragastric Balloon Market, By End User (USD Million)
10.1. Global Intragastric Balloon Market Value Share and Forecast, By End User, 2023-203310.2. Ambulatory surgical centers10.3. Clinics10.4. Hospitals
11. Global Intragastric Balloon Market Forecast, 2019-2033 (USD Million)
11.1. Global Intragastric Balloon Market Size and Market Share
12. Global Intragastric Balloon Market, By Type, 2019-2033 (USD Million)
12.1. Global Intragastric Balloon Market Size and Market Share By Type (2019-2026)12.2. Global Intragastric Balloon Market Size and Market Share By Type (2027-2033)
13. Global Intragastric Balloon Market, By Administration, 2019-2033 (USD Million)
13.1. Global Intragastric Balloon Market Size and Market Share By Administration (2019-2026)13.2. Global Intragastric Balloon Market Size and Market Share By Administration (2027-2033)
14. Global Intragastric Balloon Market, By Filling Material, 2019-2033 (USD Million)
14.1. Global Intragastric Balloon Market Size and Market Share By Filling Material (2019-2026)14.2. Global Intragastric Balloon Market Size and Market Share By Filling Material (2027-2033)
15. Global Intragastric Balloon Market, By End User, 2019-2033 (USD Million)
15.1. Global Intragastric Balloon Market Size and Market Share By End User (2019-2026)15.2. Global Intragastric Balloon Market Size and Market Share By End User (2027-2033)
16. Global Intragastric Balloon Market, By Region, 2019-2033 (USD Million)
16.1. Global Intragastric Balloon Market Size and Market Share By Region (2019-2026)16.2. Global Intragastric Balloon Market Size and Market Share By Region (2027-2033)16.3. Asia-Pacific
16.3.1. Australia16.3.2. China16.3.3. India16.3.4. Japan16.3.5. South Korea16.3.6. Rest of Asia-Pacific
16.4. Europe
16.4.1. France16.4.2. Germany16.4.3. Italy16.4.4. Spain16.4.5. United Kingdom16.4.6. Rest of Europe
16.5. Middle East and Africa
16.5.1. Kingdom of Saudi Arabia16.5.2. United Arab Emirates16.5.3. Rest of Middle East & Africa
16.6. North America
16.6.1. Canada16.6.2. Mexico16.6.3. United States16.7. Latin America
16.7.1. Argentina
16.7.2. Brazil16.7.3. Rest of Latin America
17. Company Profile
17.1. Allurion Technologies, Inc.
17.1.1. Company details17.1.2. Financial outlook17.1.3. Product summary17.1.4. Recent developments
17.2. Apollo Endosurgery, Inc.
17.2.1. Company details17.2.2. Financial outlook17.2.3. Product summary17.2.4. Recent developments
17.3. Endalis
17.3.1. Company details17.3.2. Financial outlook17.3.3. Product summary17.3.4. Recent developments
17.4. Helioscopie
17.4.1. Company details17.4.2. Financial outlook17.4.3. Product summary17.4.4. Recent developments
17.5. Lexel Medical
17.5.1. Company details17.5.2. Financial outlook17.5.3. Product summary17.5.4. Recent developments
17.6. MEDSIL
17.6.1. Company details17.6.2. Financial outlook17.6.3. Product summary17.6.4. Recent developments
17.7. Obalon Therapeutics, Inc.
17.7.1. Company details17.7.2. Financial outlook17.7.3. Product summary17.7.4. Recent developments
17.8. ReShape Medical, Inc.
17.8.1. Company details17.8.2. Financial outlook17.8.3. Product summary17.8.4. Recent developments
17.9. Spatz3
17.9.1. Company details17.9.2. Financial outlook17.9.3. Product summary17.9.4. Recent developments
17.10. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Intragastric Balloon Market is projected to reach USD 0.38 billion by 2033, growing at a CAGR of 17.31% during the forecast period.
Intragastric Balloon Market grew in market size from 2022. The Market is expected to reach USD 0.38 billion by 2033, at a CAGR of 17.31% during the forecast period.
Intragastric Balloon Market CAGR of 17.31% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Intragastric Balloon Market size is USD 0.38 billion from 2023 to 2033.
Intragastric Balloon Market Segment is covered By Type, By Administration, By Filling Material, By End User.
The North America region is anticipated to have the highest market share in the Intragastric Balloon Market.
"The key players in the market include Companies Covered Allurion Technologies, Inc., Apollo Endosurgery, Inc., Endalis, Helioscopie, Lexel Medical, MEDSIL, Obalon Therapeutics, Inc., ReShape Medical, Inc., Spatz3, others.
"
The balloon helps people lose weight by limiting the amount of food they can eat and encouraging a fullness feeling by taking up space in the stomach. This procedure is particularly beneficial for individuals who are overweight and at risk of serious weight-related health conditions such as heart disease, stroke, high blood pressure, and type II diabetes.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
